Evidence map›Paper›PMID 33028961›Full record

ArticleScientific reports2020

Common evolutionary features of the envelope glycoprotein of HIV-1 in patients belonging to a transmission chain.

Maxime Beretta, Julie Migraine, Alain Moreau, Asma Essat, Cécile Goujard, Marie-Laure Chaix, Aurélie Drouin, Mélanie Bouvin-Pley, Laurence Meyer, Francis Barin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Maxime BerettaUniversité de Tours et CHRU de Tours, Inserm U1259, Tours, France.
Julie MigraineUniversité de Tours et CHRU de Tours, Inserm U1259, Tours, France.
Alain MoreauUniversité de Tours et CHRU de Tours, Inserm U1259, Tours, France.
Asma EssatUniversité Paris Sud, Université Paris Saclay, CESP Inserm U1018, Le Kremlin-Bicêtre, France.
Cécile GoujardUniversité Paris Sud, Université Paris Saclay, CESP Inserm U1018, Le Kremlin-Bicêtre, France.
Marie-Laure ChaixUniversité de Paris, Inserm U944, Paris, France.
Aurélie DrouinUniversité de Tours et CHRU de Tours, Inserm U1259, Tours, France.
Mélanie Bouvin-PleyUniversité de Tours et CHRU de Tours, Inserm U1259, Tours, France.
Laurence MeyerUniversité Paris Sud, Université Paris Saclay, CESP Inserm U1018, Le Kremlin-Bicêtre, France.
Francis BarinUniversité de Tours et CHRU de Tours, Inserm U1259, Tours, France.
Martine BraibantUniversité de Tours et CHRU de Tours, Inserm U1259, Tours, France. braibant@med.univ-tours.fr.
Université de Tours · FRCentre Hospitalier Universitaire de Tours · FRUniversité Paris-Sud · FRAssistance Publique – Hôpitaux de Paris · FRHôpital Saint-Louis · FRInserm · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diversity of the HIV-1 envelope glycoproteins (Env) is largely a consequence of the pressure exerted by the adaptive immune response to infection. While it was generally assumed that the neutralizing antibody (NAb) response depended mainly on the infected individual, the concept that virus-related factors could be important in inducing this response has recently emerged. Here, we analyzed the influence of the infecting viral strain in shaping NAb responses in four HIV-1 infected subjects belonging to a transmission chain. We also explored the impact of NAb responses on the functional evolution of the viral quasispecies. The four patients developed a strong autologous neutralizing antibody response that drove viral escape and coincided with a parallel evolution of their infecting quasispecies towards increasing infectious properties, increasing susceptibility to T20 and increasing resistance to both CD4 analogs and V3 loop-directed NAbs. This evolution was associated with identical Env sequence changes at several positions in the V3 loop, the fusion peptide and the HR2 domain of gp41. The common evolutionary pattern of Env in different hosts suggests that the capacity of a given Env to adapt to changing environments may be restricted by functional constraints that limit its evolutionary landscape.

Indexed as

Evolution, MolecularHIV-1HIV InfectionsHumansMaleMonocytesViral Envelope ProteinsViral Envelope Proteins

Identifiers

PMID33028961
PMCPMC7541522
OpenAlexW3091800776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.